ALK-Abelló A/S
ALK-Abelló A/S (AKBLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AKBLF · as of Jun 9, 2026
Key Statistics
Explore ALK-Abelló A/S Data
akblf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
akblf competitorsAKBLF
CAMRF
CLCGY
CSMYF
FLMNY
GNGBFStock Performance
Full HistoryAbout ALK-Abelló A/S
ALK-Abelló A/S Established in 1923 and headquartered in Hørsholm, Denmark, ALK-Abelló A/S is a global pharmaceutical enterprise specializing in allergy treatment. The company provides a comprehensive range of allerg…
what is alk-abelló a/s · akblf stock overview · alk-abelló a/s company profile · who is alk-abelló a/s ceo · akblf OTC · alk-abelló a/s headquarters · alk-abelló a/s business segments
About Stock Overview & Key Data
ALK-Abelló A/S (AKBLF) is a Healthcare company in the Biotechnology industry, listed on OTC since Nov 16, 2009. As of the latest trading session, AKBLF stock price is $31.35, with a market capitalization of $6.3B. The stock has returned +16.15% over the past 12 months and -13.16% year-to-date.
According to 1 Wall Street analysts, the consensus rating for ALK-Abelló A/S stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, ALK-Abelló A/S reported revenue of $6.3B and net income of $1.2B. For detailed data — including ALK-Abelló A/S revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ALK-Abelló A/S (AKBLF) stock price is $31.35. The stock is traded on OTC under the ticker symbol AKBLF. The 52-week range is $26.99 – $38.89.